Canopy Growth (CGC) Stock Price, News & Analysis

Company Overview

Canopy Growth Corporation, founded in 2013 and headquartered in Smiths Falls, Ontario, is one of the world’s largest and most diversified cannabis companies. Originally established as Tweed Marijuana Inc., the company has grown through strategic acquisitions and organic expansion to develop a broad portfolio of cannabis and hemp-based products for both medical and adult-use markets. Canopy Growth was an early entrant in Canada’s regulated recreational market following legalization in 2018 and is listed on the NASDAQ under the ticker CGC.

The company’s product offerings span dried flower, oils, soft gel capsules, vaporizers, edibles and beverages. Under flagship brands such as Tweed and Tokyo Smoke, Canopy Growth markets a range of formats tailored to consumer preferences, while Spectrum Therapeutics addresses patient needs with pharmaceutical-grade extracts and consistent dosing. Canopy Growth has also invested in research and development to explore innovative delivery methods and new cannabinoid formulations, collaborating with academic and industry partners to advance scientific understanding.

In addition to its strong presence in Canada, Canopy Growth has established international operations and partnerships across Europe, Latin America and Australia. The company holds production facilities in Germany and the United Kingdom, and has alliances with local growers and distributors to navigate regulatory regimes and expand its global footprint. A strategic partnership with Constellation Brands, initiated in 2017, supports the development of cannabis-infused beverages and related R&D efforts aimed at commercializing novel products.

Leadership at Canopy Growth is guided by Chief Executive Officer David Klein, who joined the company in 2020, and a board of directors with experience in consumer packaged goods, pharmaceuticals and agriculture. Under their stewardship, Canopy Growth continues to focus on operational efficiencies, innovation and regulatory compliance, positioning itself for long-term growth as global markets evolve and consumer interest in cannabis products increases.

Key Stats

• Today's Range: $1.13 to $1.17
• 50-Day Range: $1.13 to $1.93
• 52-Week Range: $0.77 to $8.65
• Volume: 5.78 million shs
• Average Volume: 6.58 million shs
• Market Capitalization: $210.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Canopy Growth Stock Analysis - MarketRank™

Canopy Growth scored higher than 8% of companies evaluated by MarketBeat, and ranked 914th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Canopy Growth.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Canopy Growth are expected to grow in the coming year, from ($2.81) to ($0.69) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Canopy Growth is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Canopy Growth is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Canopy Growth has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.18% of the float of Canopy Growth has been sold short.

Short Interest Ratio / Days to Cover

Canopy Growth has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Canopy Growth has recently increased by 3.36%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Canopy Growth does not currently pay a dividend.

Dividend Growth

Canopy Growth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 0.0 / 5
• Environmental Score: -0.83

Percentage of Shares Shorted

10.18% of the float of Canopy Growth has been sold short.

Short Interest Ratio / Days to Cover

Canopy Growth has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Canopy Growth has recently increased by 3.36%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.94

News Sentiment

Canopy Growth has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Canopy Growth this week, compared to 6 articles on an average week.

Search Interest

8 people have searched for CGC on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is a decrease of -38% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Canopy Growth insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.30% of the stock of Canopy Growth is held by insiders.

Percentage Held by Institutions

Only 3.33% of the stock of Canopy Growth is held by institutions.

CGC Stock Analysis - Frequently Asked Questions

How have CGC shares performed this year?

Canopy Growth's stock was trading at $2.74 at the beginning of the year. Since then, CGC shares have decreased by 58.2% and is now trading at $1.1450.

How were Canopy Growth's earnings last quarter?

Canopy Growth Corporation (NASDAQ:CGC) issued its quarterly earnings data on Friday, May, 30th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.66. The business had revenue of $45.30 million for the quarter, compared to the consensus estimate of $71.84 million. Canopy Growth had a negative net margin of 195.76% and a negative trailing twelve-month return on equity of 88.54%.
Read the conference call transcript.

When did Canopy Growth's stock split?

Canopy Growth's stock reverse split on the morning of Wednesday, December 20th 2023.The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Canopy Growth's major shareholders?

Top institutional shareholders of Canopy Growth include Baader Bank Aktiengesellschaft (0.07%) and Wealth Enhancement Advisory Services LLC (0.02%). Insiders that own company stock include Judy Eun Joo Hong, Theresa Yanofsky, David Angelo Lazzarato, Willy Kruh and Thomas Carlton Stewart.
View institutional ownership trends.

How do I buy shares of Canopy Growth?

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include NVIDIA (NVDA), Meta Platforms (META), Alibaba Group (BABA), Micron Technology (MU), GE Aerospace (GE), BMO Capital Markets () and Stifel Nicolaus ().

Company Calendar

• Last Earnings: 5/30/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/08/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CGC
• CIK: 1737927
• Web: www.canopygrowth.com
• Phone: (855) 558-9333
• Fax: N/A
• Employees: 3,150
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($4.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$429.86 million
• Net Margins: -195.76%
• Pretax Margin: -221.94%
• Return on Equity: -88.54%
• Return on Assets: -40.78%

Debt

• Debt-to-Equity Ratio: 0.62
• Current Ratio: 3.12
• Quick Ratio: 2.10

Sales & Book Value

• Annual Sales: $225.65 million
• Price / Sales: 0.92
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.90 per share
• Price / Book: 0.60

Miscellaneous

• Outstanding Shares: 183,870,000
• Free Float: 181,475,000
• Market Cap: $208.69 million
• Optionable: Optionable
• Beta: 0.73